[This Week's IPO] December Third Week Demand Forecast and Subscription Schedule

[Asia Economy Reporter Jang Hyowon] In the third week of this month (December), Bionote is preparing for its public subscription.

◆Bionote= Bionote conducted an institutional demand forecast on the 8th and 9th. The expected public offering price band is 18,000 to 22,000 KRW, with a maximum public offering amount of 286 billion KRW. Once the offering price is set, the public subscription will take place on the 13th and 14th. NH Investment & Securities and Korea Investment & Securities are jointly managing the listing.

Established in 2003, Bionote mainly operates in animal diagnostic testing products and bio-content businesses. Based on the company's proprietary recombinant antigen and antibody technology development capabilities and manufacturing technology, it has shown prominence in immunodiagnostics.

This content was produced with the assistance of AI translation services.